21 of May, 2024
ADmit Therapeutics, has been selected to be part of the prestigious Alzheimer’s Moonshot Community driven by StartUp Health. This initiative brings together startups, investors and organisations focused on accelerating transformative solutions for the prevention, detection and treatment of Alzheimer’s disease.
Through this inclusion, ADmit Therapeutics will have access to a global network of strategic support, collaboration opportunities, visibility to investors and expert digital health mentors, which will strengthen its mission to shift the paradigm of Alzheimer’s diagnosis towards earlier, more accessible and accurate approaches.
